158 related articles for article (PubMed ID: 31757413)
1. Rational approaches of drug design for the development of selective estrogen receptor modulators (SERMs), implicated in breast cancer.
Makar S; Saha T; Swetha R; Gutti G; Kumar A; Singh SK
Bioorg Chem; 2020 Jan; 94():103380. PubMed ID: 31757413
[TBL] [Abstract][Full Text] [Related]
2. A precisely substituted benzopyran targets androgen refractory prostate cancer cells through selective modulation of estrogen receptors.
Kumar R; Verma V; Sharma V; Jain A; Singh V; Sarswat A; Maikhuri JP; Sharma VL; Gupta G
Toxicol Appl Pharmacol; 2015 Mar; 283(3):187-97. PubMed ID: 25655200
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of novel indole-xanthendione hybrids as selective estrogen receptor modulators.
Singla R; Gupta KB; Upadhyay S; Dhiman M; Jaitak V
Bioorg Med Chem; 2018 Jan; 26(1):266-277. PubMed ID: 29198894
[TBL] [Abstract][Full Text] [Related]
4. Discovery of potent ligands for estrogen receptor beta by structure-based virtual screening.
Shen J; Tan C; Zhang Y; Li X; Li W; Huang J; Shen X; Tang Y
J Med Chem; 2010 Jul; 53(14):5361-5. PubMed ID: 20553023
[TBL] [Abstract][Full Text] [Related]
5. Nitric Oxide-Releasing Selective Estrogen Receptor Modulators: A Bifunctional Approach to Improve the Therapeutic Index.
Bechmann N; Kniess T; Pietzsch J
J Med Chem; 2019 Jul; 62(14):6525-6539. PubMed ID: 31099568
[TBL] [Abstract][Full Text] [Related]
6. New scaffolds for the design of selective estrogen receptor modulators.
Martín-Santamaría S; Rodríguez JJ; de Pascual-Teresa S; Gordon S; Bengtsson M; Garrido-Laguna I; Rubio-Viqueira B; López-Casas PP; Hidalgo M; de Pascual-Teresa B; Ramos A
Org Biomol Chem; 2008 Oct; 6(19):3486-96. PubMed ID: 19082149
[TBL] [Abstract][Full Text] [Related]
7. Medicinal chemistry and emerging strategies applied to the development of selective estrogen receptor modulators (SERMs).
Musa MA; Khan MO; Cooperwood JS
Curr Med Chem; 2007; 14(11):1249-61. PubMed ID: 17504144
[TBL] [Abstract][Full Text] [Related]
8. Identification of 10-dehydrooxyglycyuralin E as a selective human estrogen receptor alpha partial agonist.
Saito N; Kawase K; Yamashita N; Tang Y; Wang Y; Wang J; Liu Y; Li N; Li W; Cheng MS; Koike K; Kanno Y; Nemoto K
Bioorg Chem; 2019 Jul; 88():102977. PubMed ID: 31100617
[TBL] [Abstract][Full Text] [Related]
9. Benzothiophene selective estrogen receptor modulators with modulated oxidative activity and receptor affinity.
Qin Z; Kastrati I; Chandrasena RE; Liu H; Yao P; Petukhov PA; Bolton JL; Thatcher GR
J Med Chem; 2007 May; 50(11):2682-92. PubMed ID: 17489582
[TBL] [Abstract][Full Text] [Related]
10. Phenytoin is an estrogen receptor α-selective modulator that interacts with helix 12.
Fadiel A; Song J; Tivon D; Hamza A; Cardozo T; Naftolin F
Reprod Sci; 2015 Feb; 22(2):146-55. PubMed ID: 25258361
[TBL] [Abstract][Full Text] [Related]
11. Estrogen signaling: An emanating therapeutic target for breast cancer treatment.
Saha T; Makar S; Swetha R; Gutti G; Singh SK
Eur J Med Chem; 2019 Sep; 177():116-143. PubMed ID: 31129450
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer.
Katzenellenbogen BS; Katzenellenbogen JA
Breast Cancer Res; 2000; 2(5):335-44. PubMed ID: 11250726
[TBL] [Abstract][Full Text] [Related]
13. Binding capacity of ER-α ligands and SERMs: comparison of the human, dog and cat.
Toniti W; Suthiyotha N; Puchadapirom P; Jenwitheesuk E
Asian Pac J Cancer Prev; 2011; 12(11):2875-9. PubMed ID: 22393957
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of cyclopropyl analogues of stilbene with raloxifene side chain as subtype-selective ligands for estrogen receptor.
Yeo HL; Song YS; Ryu JH; Kim HD
Arch Pharm Res; 2013 Sep; 36(9):1096-103. PubMed ID: 23613312
[TBL] [Abstract][Full Text] [Related]
15. Novel SERMs based on 3-aryl-4-aryloxy-2H-chromen-2-one skeleton - A possible way to dual ERα/VEGFR-2 ligands for treatment of breast cancer.
Luo G; Li X; Zhang G; Wu C; Tang Z; Liu L; You Q; Xiang H
Eur J Med Chem; 2017 Nov; 140():252-273. PubMed ID: 28942113
[TBL] [Abstract][Full Text] [Related]
16. m-Carborane bisphenol structure as a pharmacophore for selective estrogen receptor modulators.
Ogawa T; Ohta K; Yoshimi T; Yamazaki H; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem Lett; 2006 Aug; 16(15):3943-6. PubMed ID: 16735120
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel cyclopropyl derivatives as subtype-selective ligands for estrogen receptor.
Wang Z; Yang Y; Zheng X; Zhang T; Huang W; Yan D; Zhang W; Wang X; Shen Z
J Pharm Pharmacol; 2018 Jul; 70(7):910-918. PubMed ID: 29582419
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
[TBL] [Abstract][Full Text] [Related]
19. The molecular mechanisms underlying the pharmacological actions of ER modulators: implications for new drug discovery in breast cancer.
McDonnell DP; Wardell SE
Curr Opin Pharmacol; 2010 Dec; 10(6):620-8. PubMed ID: 20926342
[TBL] [Abstract][Full Text] [Related]
20. Integrating medicinal chemistry, organic/combinatorial chemistry, and computational chemistry for the discovery of selective estrogen receptor modulators with Forecaster, a novel platform for drug discovery.
Therrien E; Englebienne P; Arrowsmith AG; Mendoza-Sanchez R; Corbeil CR; Weill N; Campagna-Slater V; Moitessier N
J Chem Inf Model; 2012 Jan; 52(1):210-24. PubMed ID: 22133077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
